Meeting
Abstract Number: 0108
SHM Converge 2025
Background: Inpatient hypoglycemia (HG) is common and often avoidable, associated with poor outcomes and high costs, and its prevention reflects hospital performance. We investigated its risk factors and impact on mortality, hospital length of stay (LOS), charges, and readmissions. We defined HG as glucose ≤40 mg/dl (severe), >40 – ≤70 mg/dl (moderate), or euglycemia >70 [...]
Abstract Number: 0127
SHM Converge 2025
Background: Onodera’s prognostic nutritional index (PNI) is useful in predicting prognosis of various diseases. In hospitalized patients, malnutrition is an important factor that affects the quality of life and morbidity. Here, we aimed to evaluate whether PNI is related with clinical outcomes in patients who admitted to hospitalist ward. Methods: This study included 3,993 patients [...]
Abstract Number: 0153
SHM Converge 2025
Background: In 2019, the US Food & Drug Administration issued a warning regarding safety of gabapentin use in patients with respiratory conditions, including chronic obstructive pulmonary disease (COPD). Gabapentin is widely prescribed, often for off-label indications, however limited data exist regarding safety and outcomes among patients with COPD. Methods: We analyzed data from 29 US [...]